Terms: = Prostate cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Prognosis
2 results:
1. Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.
Liao J; Ye Y; Xu X
Clin Transl Oncol; 2022 Oct; 24(10):1986-1997. PubMed ID: 35732871
[TBL] [Abstract] [Full Text] [Related]
2. nrg1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Prentice LM; Shadeo A; Lestou VS; Miller MA; deLeeuw RJ; Makretsov N; Turbin D; Brown LA; Macpherson N; Yorida E; Cheang MC; Bentley J; Chia S; Nielsen TO; Gilks CB; Lam W; Huntsman DG
Oncogene; 2005 Nov; 24(49):7281-9. PubMed ID: 16027731
[TBL] [Abstract] [Full Text] [Related]